Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06819774 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Phase III Clinical Study of Cetirizine Hydrochloride Injection in Treatment of Acute Urticaria

Study acronym: Phase III
StatusRecruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated February 11, 2025 (before its estimated August 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
The objective of this study was to evaluate the efficacy and safety of cetirizine hydrochloride injection in the treatment of acute urticaria.The participants were randomized to receive cetirizine hydrochloride or diphenhydramine hydrochloride.
Trial Details
NCT Number NCT06819774
Lead Sponsor Shandong New Time Pharmaceutical Co., LTD
Conditions
(from sponsor)		 Acute Urticaria
Enrollment 284 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov